Jean Mixer Joins NxStage Board of Directors
NxStage® Medical (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, today announced the appointment of Jean Mixer to its Board of Directors.
Ms. Mixer is the Chief Executive Officer of mixerconsulting which focuses on helping organizations grow their business through strategic and governance work. She was formerly a partner at The Boston Consulting Group (BCG), a global strategy consulting firm, where she worked for over a decade. She has worked across the restructuring healthcare value chain including working with leading biopharmaceutical, medical device, pharmacy, insurance and integrated health care delivery networks. Prior to joining BCG, Ms. Mixer was an officer at JP Morgan in New York. She brings 25 years of public company experience.
Since 2006 Ms. Mixer has served as a Director on the Board of the Cambridge Trust Company, Chair of the Compensation Committee, and a member of the Executive Committee. She is also the Chair of the HR board committee for the Boys and Girls Clubs of Boston. Formerly, she served on the Business Round Table Committee on National Health Care Reform.
"We are delighted that Jean has joined the Board of Directors of NxStage Medical," said Jeffrey Burbank, Chief Executive Officer, NxStage Medical, Inc. "Jean's experience in strategic development within the healthcare industry, coupled with her business acumen, will bring additional valuable perspective to our Board. I look forward to her contributions as we advance NxStage's growth strategy."
"I am excited to join the Board of Directors of a health care company pioneering significant advancements in renal care," stated Ms. Mixer. "NxStage's innovative technologies have the potential to deliver life-changing outcomes for patients. NxStage's solutions enable patients to do their dialysis treatments more frequently in home, aligning well with the increasing focus of policymakers, payers and healthcare providers on superior outcomes and more patient-centered care in the home."
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.